Aventis reforms hit by takeover bid_2
7 September 2012
A hostile takeover bid threatens to frustrate a major reorganisation of purchasing at Franco-German pharmaceutical group Aventis.
Even without the bid, finding key staff to deliver the benefits of a new global category management structure had proved difficult, according to Kai Nowosel, head of global purchasing, commercial operations at Aventis.
But the €46 billion bid by rival firm Sanofi-Synthelabo, currently going through the French courts, has made the task even tougher because a...